Insider · CIK 0001251213

BENTSUR RON

Reports to the SEC for 6 companies · FORT LEE, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001251213

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-30	NVCTNuvectis Pharma, Inc.P Purchase	Director, Chairman & CEO, 10% Owner	PPurchase	+12.5K sh	$20.00	+$250K	3,688,424
2026-01-06	NVCTNuvectis Pharma, Inc.A Award	Director, Chairman & CEO, 10% Owner	AAward	+150K sh	—	—	3,675,924
2025-11-05	NVCTNuvectis Pharma, Inc.P Purchase	Director, Chairman & CEO, 10% Owner	PPurchase	+5,000 sh	$5.72	+$28.6K	3,525,924
2025-01-02	NVCTNuvectis Pharma, Inc.A Award	Director, Chairman & CEO, 10% Owner	AAward	+250K sh	—	—	3,520,924
2024-12-24	NVCTNuvectis Pharma, Inc.P Purchase	Director, Chairman & CEO, 10% Owner	PPurchase	+4,500 sh	$4.65	+$20.9K	3,270,924
2024-11-22	XAIRBeyond Air, Inc. · Stock Options (Right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−40K sh	—	—	0
2024-11-22	XAIRBeyond Air, Inc. · Stock Options (Right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−45K sh	—	—	0
2024-11-22	XAIRBeyond Air, Inc. · Stock Options (Right to buy)A Award	Director	AAward	+24K sh	—	—	24,000
2024-11-22	XAIRBeyond Air, Inc. · Stock Options (Right to buy)A Award	Director	AAward	+25K sh	—	—	25,000
2024-11-22	XAIRBeyond Air, Inc. · Stock Options (Right to buy)A Award	Director	AAward	+45K sh	—	—	45,000
2024-11-22	XAIRBeyond Air, Inc. · Stock Options (Right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−24K sh	—	—	0
2024-11-22	XAIRBeyond Air, Inc. · Stock Options (Right to buy)A Award	Director	AAward	+25K sh	—	—	25,000
2024-11-22	XAIRBeyond Air, Inc. · Stock Options (Right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−25K sh	—	—	0
2024-11-22	XAIRBeyond Air, Inc. · Stock Options (Right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−30K sh	—	—	0
2024-11-22	XAIRBeyond Air, Inc. · Stock Options (Right to buy)A Award	Director	AAward	+30K sh	—	—	30,000
2024-11-22	XAIRBeyond Air, Inc. · Stock Options (Right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−25K sh	—	—	0
2024-11-22	XAIRBeyond Air, Inc. · Stock Options (Right to buy)A Award	Director	AAward	+40K sh	—	—	40,000
2024-11-15	NVCTNuvectis Pharma, Inc.P Purchase	Director, Chairman & CEO, 10% Owner	PPurchase	+20K sh	$4.92	+$98.4K	3,266,424
2024-05-14	NVCTNuvectis Pharma, Inc.P Purchase	Director, Chairman & CEO, 10% Owner	PPurchase	+1,940 sh	$6.74	+$13.1K	3,246,424
2024-05-10	NVCTNuvectis Pharma, Inc.P Purchase	Director, Chairman & CEO, 10% Owner	PPurchase	+2,000 sh	$6.40	+$12.8K	3,244,484
2024-03-20	XAIRBeyond Air, Inc. · Stock Option (right to buy)A Award	Director	AAward	+45K sh	—	—	45,000
2024-03-18	NVCTNuvectis Pharma, Inc.P Purchase	Director, Chairman & CEO, 10% Owner	PPurchase	+5,000 sh	$10.29	+$51.4K	3,242,484
2023-10-10	NVCTNuvectis Pharma, Inc.P Purchase	Director, Chairman & CEO, 10% Owner	PPurchase	+640 sh	$11.08	+$7,091.2	3,237,484
2023-10-09	NVCTNuvectis Pharma, Inc.P Purchase	Director, Chairman & CEO, 10% Owner	PPurchase	+830 sh	$11.19	+$9,287.7	3,236,844
2023-10-06	NVCTNuvectis Pharma, Inc.P Purchase	Director, Chairman & CEO, 10% Owner	PPurchase	+250 sh	$11.27	+$2,817.5	3,236,014
2023-10-05	NVCTNuvectis Pharma, Inc.P Purchase	Director, Chairman & CEO, 10% Owner	PPurchase	+1,400 sh	$11.09	+$15.5K	3,235,764
2023-10-04	NVCTNuvectis Pharma, Inc.P Purchase	Director, Chairman & CEO, 10% Owner	PPurchase	+1,820 sh	$10.95	+$19.9K	3,234,364
2023-08-16	NVCTNuvectis Pharma, Inc.P Purchase	Director, Chairman & CEO, 10% Owner	PPurchase	+115 sh	$15.15	+$1,742.25	3,232,544
2023-08-15	NVCTNuvectis Pharma, Inc.P Purchase	Director, Chairman & CEO, 10% Owner	PPurchase	+235 sh	$14.34	+$3,369.9	3,232,429
2023-08-11	NVCTNuvectis Pharma, Inc.P Purchase	Director, Chairman & CEO, 10% Owner	PPurchase	+180 sh	$14.66	+$2,638.8	3,232,194
2023-08-08	NVCTNuvectis Pharma, Inc.P Purchase	Director, Chairman & CEO, 10% Owner	PPurchase	+120 sh	$14.83	+$1,779.6	3,232,014
2023-07-21	NVCTNuvectis Pharma, Inc.P Purchase	Director, Chairman & CEO, 10% Owner	PPurchase	+225 sh	$14.85	+$3,341.25	3,231,894
2023-07-20	NVCTNuvectis Pharma, Inc.P Purchase	Director, Chairman & CEO, 10% Owner	PPurchase	+110 sh	$15.06	+$1,656.6	3,231,669
2023-07-19	NVCTNuvectis Pharma, Inc.P Purchase	Director, Chairman & CEO, 10% Owner	PPurchase	+200 sh	$14.33	+$2,866	3,231,559
2023-07-14	NVCTNuvectis Pharma, Inc.P Purchase	Director, Chairman & CEO, 10% Owner	PPurchase	+150 sh	$15.03	+$2,254.5	3,231,359
2023-07-07	NVCTNuvectis Pharma, Inc.P Purchase	Director, Chairman & CEO, 10% Owner	PPurchase	+110 sh	$16.19	+$1,780.9	3,231,209
2023-07-06	NVCTNuvectis Pharma, Inc.P Purchase	Director, Chairman & CEO, 10% Owner	PPurchase	+320 sh	$14.88	+$4,761.6	3,231,099
2023-06-26	NVCTNuvectis Pharma, Inc.P Purchase	Director, Chairman & CEO, 10% Owner	PPurchase	+750 sh	$16.50	+$12.4K	3,230,779
2023-06-21	NVCTNuvectis Pharma, Inc.P Purchase	Director, Chairman & CEO, 10% Owner	PPurchase	+500 sh	$17.88	+$8,940	3,230,029
2023-06-08	NVCTNuvectis Pharma, Inc.P Purchase	Director, Chairman & CEO, 10% Owner	PPurchase	+120 sh	$17.53	+$2,103.6	3,229,529
2023-06-07	NVCTNuvectis Pharma, Inc.P Purchase	Director, Chairman & CEO, 10% Owner	PPurchase	+230 sh	$17.41	+$4,004.3	3,229,409
2023-05-31	NVCTNuvectis Pharma, Inc.P Purchase	Director, Chairman & CEO, 10% Owner	PPurchase	+330 sh	$17.28	+$5,702.4	3,229,179
2023-05-24	NVCTNuvectis Pharma, Inc.P Purchase	Director, Chairman & CEO, 10% Owner	PPurchase	+200 sh	$17.49	+$3,498	3,228,849
2023-05-16	NVCTNuvectis Pharma, Inc.P Purchase	Director, Chairman & CEO, 10% Owner	PPurchase	+320 sh	$17.02	+$5,448	3,228,649
2023-03-23	NVCTNuvectis Pharma, Inc.P Purchase	Director, Chairman & CEO, 10% Owner	PPurchase	+230 sh	$12.13	+$2,789.9	3,228,329
2023-03-21	NVCTNuvectis Pharma, Inc.P Purchase	Director, Chairman & CEO, 10% Owner	PPurchase	+480 sh	$12.08	+$5,798.4	3,228,099
2023-03-20	XAIRBeyond Air, Inc.P Purchase	Director	PPurchase	+2,300 sh	$6.48	+$14.9K	144,736
2023-03-15	NVCTNuvectis Pharma, Inc.P Purchase	Director, Chairman & CEO, 10% Owner	PPurchase	+480 sh	$10.91	+$5,236.8	3,227,619
2023-03-14	NVCTNuvectis Pharma, Inc.P Purchase	Director, Chairman & CEO, 10% Owner	PPurchase	+1,680 sh	$10.85	+$18.2K	3,227,139
2023-01-12	NVCTNuvectis Pharma, Inc.A Award	Director, Chairman & CEO, 10% Owner	AAward	+210K sh	—	—	3,225,459

Recent filings

Accepted (ET)
Jul 14
BENTSUR RON0001104659-26-079792
SEC(opens sec.gov)
Jan 94
BENTSUR RON0001104659-26-002500
SEC(opens sec.gov)
Nov 64
BENTSUR RON0001104659-25-107423
SEC(opens sec.gov)
Jan 34
BENTSUR RON0001104659-25-000909
SEC(opens sec.gov)
Dec 264
BENTSUR RON0001104659-24-131541
SEC(opens sec.gov)
Nov 264
BENTSUR RON0001493152-24-047888
SEC(opens sec.gov)
Nov 184
BENTSUR RON0001104659-24-119976
SEC(opens sec.gov)
May 154
BENTSUR RON0001104659-24-061674
SEC(opens sec.gov)
May 134
BENTSUR RON0001104659-24-060263
SEC(opens sec.gov)

Companies

Address

C/O NUVECTIS PHARMA, INC. 1 BRIDGE PLAZA, SUITE 275

FORT LEE, NJ, 07024